Aardvark Therapeutics (AARD) Q4 2025 Earnings

13NovConfirmed
Q2 2025
Q3 2025
Q4 2025
-0.8
-0.73
-0.67
-0.6

Details

Expected EPS
-0.798571
Actual EPS
-0.75
Surprise EPS
0.05
Surprise Percent
+6.08%

Description

Aardvark Therapeutics (AARD) has reported earnings of -0.75 per share for Q4 2025.

0 Comments

Share your thoughts